{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:16:13Z","timestamp":1789913773391,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ejpb.2012.02.014","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T01:54:54Z","timestamp":1331949294000},"page":"257-264","source":"Crossref","is-referenced-by-count":120,"title":["Novel micelle carriers for cyclosporin A topical ocular delivery: In vivo cornea penetration, ocular distribution and efficacy studies"],"prefix":"10.1016","volume":"81","author":[{"given":"Claudia","family":"Di Tommaso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Bourges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Valamanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Trubitsyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Torriglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Jeanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gurny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2012.02.014_b0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainresbull.2009.05.019","article-title":"Corneal transparency: genesis, maintenance and dysfunction","volume":"81","author":"Qazi","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejpb.2012.02.014_b0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/01.tp.0000285489.91595.13","article-title":"The immunobiology of corneal transplantation","volume":"84","author":"Williams","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ejpb.2012.02.014_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1385\/CRIAI:20:2:215","article-title":"Immunology of corneal transplantation","volume":"20","author":"Constad","year":"2001","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ejpb.2012.02.014_b0020","unstructured":"World Health Organization, Human Organ and Tissue, Transplantation, 2003, EB112\/5."},{"key":"10.1016\/j.ejpb.2012.02.014_b0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/13543784.12.1.29","article-title":"Recent developments in the pharmacological treatment and prevention of corneal graft rejection","volume":"12","author":"Banerjee","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejpb.2012.02.014_b0030","first-page":"110","article-title":"Effect of a cyclosporine A delivery system in corneal transplantation","volume":"115","author":"Xie","year":"2002","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejpb.2012.02.014_b0035","first-page":"356","article-title":"The side-effects of cyclosporine-A and tacrolimus","volume":"49","author":"Mihatsch","year":"1998","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ejpb.2012.02.014_b0040","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.drudis.2006.07.015","article-title":"Disease, destination, dose and delivery aspects of ciclosporin: the state of the art","volume":"11","author":"Italia","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2012.02.014_b0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2010.09.012","article-title":"Novel cyclosporin A formulations using MPEG-hexylsubstituted polylactide micelles: a suitability study","volume":"77","author":"Mondon","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.02.014_b0050","first-page":"1461","article-title":"Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats","volume":"12","author":"Bourges","year":"2006","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2012.02.014_b0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2008.04.002","article-title":"Hyaluronic acid coated poly-3-caprolactone nanospheres deliver high concentrations of cyclosporin A into the cornea","volume":"87","author":"Yenice","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2012.02.014_b0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2008.08.004","article-title":"Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results","volume":"365","author":"Gan","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.02.014_b0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2008.07.028","article-title":"Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity","volume":"364","author":"Gocke","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.02.014_b0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1076\/ceyr.17.1.39.5251","article-title":"Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat","volume":"17","author":"Juberias","year":"1998","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2012.02.014_b0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1442-9071.2008.01784.x","article-title":"Topical cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial","volume":"36","author":"Franzco","year":"2008","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejpb.2012.02.014_b0080","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/bjo.2008.143024","article-title":"Evaluation of topical cyclosporin 0.05% for prevention of rejection in high-risk corneal grafts","volume":"92","author":"Unal","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2012.02.014_b0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2006.03.036","article-title":"Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides)","volume":"319","author":"Trimaille","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.02.014_b0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1751-1097.2010.00879.x","article-title":"MPEG-hexPLA micelles as novel carriers for hypericin, a fluorescent marker for use in cancer diagnostics","volume":"87","author":"Mondon","year":"2011","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejpb.2012.02.014_b0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2011.03.003","article-title":"Novel micelle formulations to increase cutaneous bioavailability of azole antifungals","volume":"153","author":"Bachhav","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2012.02.014_b0100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijpharm.2011.01.004","article-title":"Ocular biocompatibility of novel cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers","volume":"416","author":"Di Tommaso","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.02.014_b0105","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1002\/pola.20251","article-title":"Synthesis and ring-opening polymerization of new monoalkyl-substituted lactides","volume":"42","author":"Trimaille","year":"2004","journal-title":"J. Polym. Sci. Part A: Polym. Chem."},{"key":"10.1016\/j.ejpb.2012.02.014_b0110","unstructured":"G. Trubtsyn, et al., ACS Macro Letters, submitted for publication."},{"key":"10.1016\/j.ejpb.2012.02.014_b0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejps.2010.02.006","article-title":"Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations","volume":"40","author":"Di Tommaso","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.02.014_b0120","article-title":"In vivo characterisation of a novel water-soluble cyclosporine A prodrug for the treatment of dry eye disease","author":"Rodriguez-Aller","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.02.014_b0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following topical delivery","volume":"16","author":"J\u00e4rvinen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2012.02.014_b0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000048289","article-title":"Corneal allograft rejection: current understanding","volume":"216","author":"Bertelmann","year":"2002","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ejpb.2012.02.014_b0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/108076802317233243","article-title":"Distribution of cyclosporin A in the cornea after topical or oral administration","volume":"18","author":"Theng","year":"2002","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.ejpb.2012.02.014_b0140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharma.2011.01.001","article-title":"Colloidal systems for the delivery of cyclosporin A to the anterior segment of the eye","volume":"69","author":"Di Tommaso","year":"2011","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.ejpb.2012.02.014_b0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00003226-199403000-00006","article-title":"Influence of topically applied cyclosporine A in olive oil on corneal epithelium permeability","volume":"13","author":"del Castillo","year":"1994","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2012.02.014_b0150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00003226-199109000-00003","article-title":"Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model","volume":"10","author":"Holland","year":"1991","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2012.02.014_b0155","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1007\/BF02343065","article-title":"The behavior of ED1- and ED1-positive cells in the rat iris and choroid following penetrating keratoplasty and cyclosporin A therapy","volume":"234","author":"Krause","year":"1996","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejpb.2012.02.014_b0160","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00007890-198603000-00021","article-title":"Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dog","volume":"41","author":"Gridelli","year":"1986","journal-title":"Transplantation"},{"key":"10.1016\/j.ejpb.2012.02.014_b0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-065X.1984.tb00719.x","article-title":"The inflammatory mechanisms of allograft rejection","volume":"77","author":"Hsauyry","year":"1984","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejpb.2012.02.014_b0170","first-page":"584","article-title":"Importance of the noncorneal absorption route in topical ophthalmic drug delivery","volume":"26","author":"Ahmed","year":"1985","journal-title":"Invest. Ophth. Vis. Sci."},{"key":"10.1016\/j.ejpb.2012.02.014_b0175","first-page":"650","article-title":"Intraocular penetration of topically applied cyclosporine","volume":"20","author":"Kaswan","year":"1988","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejpb.2012.02.014_b0180","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/archopht.1985.01050100135035","article-title":"Local cyclosporine therapy for experimental autoimmune uveitis in rats","volume":"103","author":"Nussenblatt","year":"1985","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejpb.2012.02.014_b0185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1023\/A:1013671819604","article-title":"Cyclosporine A formulation affect its ocular distribution in rabbits","volume":"19","author":"Kuwano","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2012.02.014_b0190","doi-asserted-by":"crossref","unstructured":"W. Johnson Jr., Cosmetic Ingredient Review Expert Panel, Authors not reported, Final Report on the Safety Assessment of Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Glyceryl Ricinoleate, Glyceryl Ricinoleate SE, Ricinoleic Acid, Potassium Ricinoleate, Sodium Ricinoleate, Zinc Ricinoleate, Cetyl Ricinoleate, Ethyl Ricinoleate, Glycol Ricinoleate, Isopropyl Ricinoleate, Methyl Ricinoleate, and Octyldodecyl Ricinoleate, Int. J. Toxicol. 26 (2007) 31\u201377.","DOI":"10.1080\/10915810701663150"},{"key":"10.1016\/j.ejpb.2012.02.014_b0195","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.ophtha.2006.05.022","article-title":"Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes","volume":"113","author":"Price","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2012.02.014_b0200","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/bjo.82.6.700","article-title":"Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model","volume":"82","author":"Reis","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2012.02.014_b0205","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.TP.0000158022.62059.F2","article-title":"Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study","volume":"79","author":"Birnbaum","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.ejpb.2012.02.014_b0210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/bjo.64.3.148","article-title":"Effect of cyclosporin A on the survival of corneal grafts in rabbits","volume":"64","author":"Shepherd","year":"1980","journal-title":"Br. J. Ophthalm."},{"key":"10.1016\/j.ejpb.2012.02.014_b0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000080937","article-title":"Immunomodulatory therapy in ophthalmology \u2013 is there a place for topical applications?","volume":"218","author":"Bertelmann","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ejpb.2012.02.014_b0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1076\/ceyr.24.1.39.5427","article-title":"Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats","volume":"24","author":"Vallelado","year":"2002","journal-title":"Curr. Eye Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T15:33:37Z","timestamp":1713713617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641112000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0939641112000707"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2012.02.014","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}